Burden of epilepsy: the Ontario Health Survey.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 10563210)

Published in Can J Neurol Sci on November 01, 1999

Authors

S Wiebe1, D R Bellhouse, C Fallahay, M Eliasziw

Author Affiliations

1: Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.

Articles citing this

The descriptive epidemiology of epilepsy-a review. Epilepsy Res (2009) 2.05

Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis (2002) 1.72

Disparities in epilepsy: report of a systematic review by the North American Commission of the International League Against Epilepsy. Epilepsia (2009) 1.41

Disparities in surgery among patients with intractable epilepsy in a universal health system. Neurology (2015) 1.08

A prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: data from the Nurses' Health Study II. Epilepsia (2009) 1.03

Network-level analysis of cortical thickness of the epileptic brain. Neuroimage (2010) 0.99

Psychiatric comorbidity in patients with epilepsy: a population-based study. Eur J Clin Pharmacol (2010) 0.93

Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgery. Ont Health Technol Assess Ser (2012) 0.89

Sydney epilepsy incidence study to measure illness consequences: the SESIMIC observational epilepsy study protocol. BMC Neurol (2011) 0.86

Determining surgical candidacy in temporal lobe epilepsy. Epilepsy Res Treat (2012) 0.80

Mortality in late post-traumatic seizures. J Neurotrauma (2009) 0.80

Epilepsy in Cambodia-treatment aspects and policy implications: a population-based representative survey. PLoS One (2013) 0.79

Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis. Syst Rev (2014) 0.78

A dyadic model of living with epilepsy based on the perspectives of adults with epilepsy and their support persons. Epilepsy Behav (2015) 0.77

Health care utilization and outpatient, out-of-pocket costs for active convulsive epilepsy in rural northeastern South Africa: a cross-sectional Survey. BMC Health Serv Res (2016) 0.75

Knowledge about and Attitude towards Epilepsy among Menit Community, Southwest Ethiopia. Ethiop J Health Sci (2017) 0.75

Assessment of psychological distress in epilepsy: perspective from pakistan. Epilepsy Res Treat (2012) 0.75

Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med (2017) 0.75

Surveying the population with epilepsy: ulcers, allergies, and other medical comorbidities. Epilepsy Curr (2007) 0.75

Articles by these authors

Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33

A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med (2001) 13.85

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (1998) 11.27

Sample size and optimal designs for reliability studies. Stat Med (1998) 6.80

Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet (2004) 5.93

Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet (2003) 5.90

The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (2000) 4.67

The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke (1999) 3.31

Sample size requirements for reliability studies. Stat Med (1987) 3.15

Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology (1996) 2.89

Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA (2000) 2.56

Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet (2001) 2.29

A goodness-of-fit approach to inference procedures for the kappa statistic: confidence interval construction, significance-testing and sample size estimation. Stat Med (1992) 2.20

Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet (1995) 2.04

Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry (2005) 1.86

Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Stroke (2000) 1.75

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71

Drugs and surgery in the prevention of ischemic stroke. N Engl J Med (1995) 1.71

Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients. Neurology (2007) 1.66

Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis. Stroke (2002) 1.61

The risk of stroke in patients with first-ever retinal vs hemispheric transient ischemic attacks and high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol (1995) 1.59

The dilemma of surgical treatment for patients with asymptomatic carotid disease. Ann Intern Med (1995) 1.50

Anterior cruciate ligament tear: prospective evaluation of diagnostic accuracy of middle- and high-field-strength MR imaging at 1.5 and 0.5 T. Radiology (1995) 1.49

The identification by imaging methods of patients who might benefit from carotid endarterectomy. Arch Neurol (1995) 1.37

Medical complications associated with carotid endarterectomy. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Stroke (1999) 1.29

Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med (2001) 1.20

Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. North American Symptomatic Carotid Endarterectomy Trial Group. Neurology (2000) 1.20

Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry (2002) 1.17

Small, unruptured intracranial aneurysms and management of symptomatic carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Group. Neurology (2000) 1.16

Long-term prognosis and effect of endarterectomy in patients with symptomatic severe carotid stenosis and contralateral carotid stenosis or occlusion: results from NASCET. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. J Neurosurg (1995) 1.12

Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts. Stroke (1996) 1.11

Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke (2004) 1.09

Methodology for inferences concerning familial correlations: a review. J Clin Epidemiol (1991) 1.09

Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The North American Symptomatic Carotid Endarterectomy Trail. Stroke (1999) 1.08

The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Neurology (1997) 1.06

Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol (1996) 1.02

Angiographic detection of carotid plaque ulceration. Comparison with surgical observations in a multicenter study. North American Symptomatic Carotid Endarterectomy Trial. Stroke (1994) 0.99

Epidemiology of temporal lobe epilepsy. Can J Neurol Sci (2000) 0.98

Duration and distance of exposure are important predictors of transmission among community contacts of Ontario SARS cases. Epidemiol Infect (2007) 0.96

Statistical implications of the choice between a dichotomous or continuous trait in studies of interobserver agreement. Biometrics (1994) 0.95

Lack of relationship between leukoaraiosis and carotid artery disease. The North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol (1995) 0.95

Statistical methodology for estimating twin similarity with respect to a dichotomous trait. Genet Epidemiol (1995) 0.92

Internal borderzone infarction: a marker for severe stenosis in patients with symptomatic internal carotid artery disease. For the North American Symptomatic Carotid Endarterectomy (NASCET) Group. Stroke (2000) 0.92

Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Arch Neurol (1994) 0.92

Endarterectomy or angioplasty for treatment of carotid stenosis? Lancet (2001) 0.92

Educational attainment and socioeconomic status of patients with autopsy-confirmed Alzheimer disease. Arch Neurol (2000) 0.91

Seizure control as an indicator of therapeutic usefulness. Can J Neurol Sci (2000) 0.91

Propofol sedation during awake craniotomy for seizures: patient-controlled administration versus neurolept analgesia. Anesth Analg (1997) 0.90

HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation (1997) 0.89

Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol (1993) 0.88

Postoperative cognitive impairment in the elderly. Choice of patient-controlled analgesia opioid. Anaesthesia (1996) 0.88

Early endarterectomy for severe carotid artery stenosis after a nondisabling stroke: results from the North American Symptomatic Carotid Endarterectomy Trial. J Vasc Surg (1994) 0.87

Evidence based cardiology: Prevention of ischaemic stroke. BMJ (1999) 0.86

Testing the homogeneity of kappa statistics. Biometrics (1996) 0.86

Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes. Mult Scler (2013) 0.85

Outcome assessment in epilepsy: comparative responsiveness of quality of life and psychosocial instruments. Epilepsia (1997) 0.85

Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans. Eur Respir J (2010) 0.85

Long-term clinical and angiographic outcomes in symptomatic patients with 70% to 99% carotid artery stenosis. Stroke (2000) 0.85

High Epstein-Barr virus-specific T-cell counts are associated with near-zero likelihood of acute myeloid leukemia relapse after hematopoietic cell transplantation. Leukemia (2011) 0.84

Changes in quality of life in epilepsy: how large must they be to be real? Epilepsia (2001) 0.82

Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia. Arch Neurol (1997) 0.81

Propofol sedation during awake craniotomy for seizures: electrocorticographic and epileptogenic effects. Anesth Analg (1997) 0.80

Safety of outpatient peripheral angioplasty. Radiology (1993) 0.80

Effect of contralateral carotid artery stenosis on carotid ultrasound velocity measurements. Stroke (2000) 0.80

Treatment of asymptomatic arteriosclerotic carotid artery disease. Adv Neurol (2003) 0.80

Risk factors for cervical atherosclerosis in patients with transient ischemic attack or minor ischemic stroke. Stroke (1994) 0.79

Influence of HLA and CREG matching in African-American primary cadaver kidney recipients: UNOS 1991-1995. Transplant Proc (1997) 0.78

Review of inference procedures for the interclass correlation coefficient with emphasis on applications to family studies. Genet Epidemiol (1998) 0.78

A comparison of methods for testing homogeneity of proportions in teratologic studies. Stat Med (1994) 0.78

Propofol and hyperventilation for the treatment of increased intracranial pressure in rabbits. Anesth Analg (1998) 0.77

A general goodness-of-fit approach for inference procedures concerning the kappa statistic. Stat Med (2001) 0.77

Effect of HLA mismatch in African-Americans. Transplantation (1998) 0.77

Application of matched pair procedures to site-specific data in periodontal research. J Clin Periodontol (1991) 0.77

Timing of carotid endarterectomy after stroke. Stroke (1998) 0.77

Long-term prognosis and the effect of carotid endarterectomy in patients with recurrent ipsilateral ischemic events. North American Symptomatic Carotid Endarterectomy Trial Group. Neurology (1996) 0.76

Measuring quality of life in epilepsy surgery patients. Can J Neurol Sci (2000) 0.76

MR imaging field strength: prospective evaluation of the diagnostic accuracy of MR for diagnosis of multiple sclerosis at 0.5 and 1.5 T. Radiology (1995) 0.75

Aspirin benefit remains elusive in primary stroke prevention. Arch Neurol (2000) 0.75

Re 'The accuracy of carotid duplex testing: there is no problem'. Stroke (1996) 0.75

Technology assessment in Canada: comparison of magnetic field strength in the assessment of complex partial seizures. Acad Radiol (1996) 0.75

Stenosis of the carotid bifurcation: subjective assessment compared with strict measurement guidelines. Can Assoc Radiol J (1993) 0.75

Stereotaxic percutaneous core biopsy versus surgical biopsy of nonpalpable breast lesions using a standard mammographic table with an add-on device. Can Assoc Radiol J (2001) 0.75

Rate of change of cerebral blood flow velocity with hyperventilation during anesthesia in humans. Can J Anaesth (2000) 0.75

A hierarchical approach to inferences concerning interobserver agreement for multinomial data. Stat Med (1997) 0.75

The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes. Med Phys (1996) 0.75

Identifying reliable change in tactile temporal thresholds in multiple sclerosis: test-retest reliability. Mult Scler (2006) 0.75

Quantification of multiple sclerosis lesion volumes in 1.5 and 0.5 T anisotropically filtered and unfiltered MR exams. Med Phys (1996) 0.75

Collaborative Evaluation of the Healthy Habits Program: An Effective Community Intervention to Improve Mobility and Cognition of Chinese Older Adults Living in the U.S. J Nutr Health Aging (2016) 0.75

Treatment of symptomatic arteriosclerotic carotid artery disease. Adv Neurol (2003) 0.75

Carotid endarterectomy: emerging indications. Baillieres Clin Neurol (1995) 0.75

Reliability of visual temporal thresholds. Can J Neurol Sci (2007) 0.75